1. Boehm, T., Folkman, J., Browder, T., O’Reilly, M.S., 1997. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature, 390(6658): 404–407. [doi:10.1038/37126]
2. Brown, L.F., Berse, B., Jackman, R.W., Tognazzi, K., Manseau, E.J., Dvorak, H.F., Senger, D.R., 1993. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol., 143(5):1255–1262.
3. Davie, E.W., Fujikawa, K., Kisiel, W., 1991. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry, 30(43):10363–10370. [doi:10.1021/bi00107a001]
4. Denekamp, J., 1993. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br. J. Radiol., 66(783):181–196.
5. Dvorak, H.F., Nagy, J.A., Dvorak, A.M., 1991. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells, 3(3): 77–85.